Go back

EMA partners up on health technology

The European Medicines Agency and the European Network for Health Technology Assessment, EUnetHTA, are to cooperate on sharing information and developing pilot projects on clinical trials and study data.

In the joint three-year working plan, published on 19 November, the bodies set out four areas to cooperate on. These are exchanging clinical trial methodologies, sharing orphan medicines information, collecting data for regulatory bodies and improving scientific advice for regulators and HTAs.

As part of this, the EMA will contribute to the EUnetHTA’s development of disease-specific guidelines, while EUnetHTA will support the EMA’s moves to boost transparency in clinical trials.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.